ASSET ACQUISITION AGREEMENT dated November 25, 2006 FOR THE ACQUISITION OF Certain of the Assets Related to Nipent® By and among MAYNE PHARMA plc And SUPERGEN, INC. and EUROGEN PHARMACEUTICALS, LTD.Asset Acquisition Agreement • November 28th, 2006 • Supergen Inc • Pharmaceutical preparations • Delaware
This Asset Acquisition Agreement (this “Agreement”), dated as of November 25, 2006, is by and among Mayne Pharma plc, a company incorporated and registered in England and Wales and/or its designee(s) (“Buyer”), EuroGen Pharmaceuticals, Ltd., a company incorporated and registered in England and Wales (“EuroGen”), and SuperGen, Inc., a Delaware corporation (“Seller”).
